intermittent fasting with semaglutide benefits for weight and wellness How Does Semaglutide Repress Appetite?

With the drugs unique ability to significantly reduce weight, GLP-1s have gained popularity among those looking to shed extra pounds

Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase

Sun, and S.C

CAS #: 60940-34-3

Analysis of relative gene expression data using real-time quantitative PCR and the 2(- C(t)) method